Skip to main content

Table 2 Pertinent characteristics of included and excluded patients

From: Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Variable Included (n = 2395) Excluded (n = 817) p value*
Age (years; mean ± SD) 58.1 (7.8) 57.9 (11.7) 0.71
Female gender (%, n) 60.8 (1457/2395) 57.8 (472/817) 0.13
BMI (kg/m2; mean ± SD) 29.4 (5.0) 29.3 (4.7) 0.38
Obesity (%, n) 40.8 (976/2395) 39.4 (318/808) 0.52
Central obesity (%, n) 60.7 (1452/2393) 60.6 (477/787) 0.81
Smoking
 Current (%, n) 16.0 (382/2395) 19.7 (161/817) 0.03
 Past (%, n) 26.2 (628/2395) 24.8 (203/817) 0.27
Hypertension (%, n) 49.1 (1175/2392) 52.1 (420/806) 0.19
Blood pressure (mmHg)
 Systolic (mean ± SD) 138.6 (17.9) 139.6 (18.3) 0.20
 Diastolic (mean ± SD) 82.8 (10.3) 84.5 (10.7) 0.0002
Blood lipids (mmol/l)
 Total cholesterol (mean ± SD) 5.63 (1.19) 5.60 (1.18) 0.63
 HDL cholesterol (mean ± SD) 1.31 (0.32) 1.30 (0.34) 0.29
 LDL cholesterol (mean ± SD) 3.58 (1.03) 3.54 (1.01) 0.52
 Triglycerides (mean ± SD) 1.66 (1.02) 1.73 (1.19) 0.56
Plasma glucose (mmol/l)
 Fasting (mean ± SD) 6.24 (0.91) 6.40 (0.83)** 0.02
 2 h postload (mean ± SD) 7.34 (2.28) 7.62 (2.26)*** 0.13
 HbA1c (%)(mean ± SD) 5.67 (0.50) 5.75 (0.67)**** 0.0003
Pharmacological treatment
 ASA/antiplatelets (%, n) 27.8 (665/2391) 25.0 (204/815) 0.14
 Lipid lowering (%, n) 31.0 (741/2391) 39.1 (318/814) < 0.0001
 Beta-blockers (%, n) 30.5 (730/2392) 31.5 (256/813) 0.53
 ACE-inhibitors (%, n) 48.2 (1153/2392) 49.0 (399/814) 0.71
 AT-II receptor blockers (%, n) 18.9 (452/2392) 19.8 (161/813) 0.56
 Calcium channel blockers (%, n) 22.4 (535/2392) 26.3 (214/814) 0.03
 Diuretics (%, n) 29.4 (703/2391) 31.5 (257/815) 0.21
 Low educational level (%, n) 10.5 (250/2382) 14.7 (120/816) 0.002
 Low or moderate physical activity (%, n) 55.4 (1295/2337) 61.5 (487/792) 0.001
  1. Obesity-BMI ≥ 30 kg/m2
  2. Central obesity-a waist circumference of ≥ 88 cm for women and ≥ 102 cm for men
  3. Hypertension—systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg
  4. Smoking—self-reported smoking or an exhaled carbon monoxide > 10 ppm
  5. The physical activity target was defined as vigorous physical activity outside work for ≥ 20 min at least once/week
  6. Low educational level—if completed only primary school or less
  7. HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ACEI angiotensin-converting enzyme inhibitor, AT-II angiotensin II receptor blockers, BMI body mass index
  8. * Significance of the difference between groups, adjusted for age and gender; **N = 177; ****N = 167; ****N = 668